MUSCARINIC M-1 AND M-2 RECEPTOR SUBTYPE-SELECTIVE DRUGS MODULATE NEOCORTICAL EEG VIA THALAMUS

Citation
J. Puolivali et al., MUSCARINIC M-1 AND M-2 RECEPTOR SUBTYPE-SELECTIVE DRUGS MODULATE NEOCORTICAL EEG VIA THALAMUS, NeuroReport, 9(8), 1998, pp. 1685-1689
Citations number
18
Categorie Soggetti
Neurosciences
Journal title
ISSN journal
09594965
Volume
9
Issue
8
Year of publication
1998
Pages
1685 - 1689
Database
ISI
SICI code
0959-4965(1998)9:8<1685:MMAMRS>2.0.ZU;2-E
Abstract
THE present study was designed to investigate the effects of infusions into reticular nucleus of thalamus (NRT) or intracerebroventricular ( i.c.v.) infusions of muscarinic M-1 and M-2 receptor subtype selective drugs on thalamocortically generated neocortical high voltage spindle s (HVSs) in awake immobile rats. NRT administration of 2.0 and 20.0 mu g McN-A-343, a muscarinic M-1 agonist, and 20.0 mu g methoctramine, a muscarinic M-2 antagonist, suppressed HVSs. The results suggest that the blockade of presynaptic M-2 receptors and activation of post-synap tic M(1 )receptors in the NRT suppress thalamocortical oscillations an d increase neocortical electrical arousal. (C) 1998 Rapid Science Ltd.